Shared Resources Management

$172,825P30FY2022CANIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39574895 Paper 39534431 Paper 39506045 Paper 39378093 Paper 39257774 Paper 39179931 Paper 39163262 Paper 39132489 Paper 39042439 Paper 38997156 Paper 38996463 Paper 38987048 Paper 38968138 Paper 38838737 Paper 38810650 Paper 38746193 Paper 38563850 Paper 38496616 Paper 38496500 Paper 38408498 Paper 38387457 Paper 38278150 Paper 38273211 Paper 38262408 Paper 38260330 Paper 38200310 Paper 38154193 Paper 38096469 Paper 37963187 Paper 37917579 Paper 37882771 Paper 37812494 Paper 37743567 Paper 37667254 Paper 37662553 Paper 37534980 Paper 37532139 Paper 37527449 Paper 37398193 Paper 37244414 Paper 37196642 Paper 37184546 Paper 37162847 Paper 36999999 Paper 36993756 Paper 36813894 Paper 36747642 Paper 36734849 Paper 36729432 Paper 36729074 Paper 36719070 Paper 36717409 Paper 36711732 Paper 36701540 Paper 36652552 Paper 36640300 Paper 36635501 Paper 36624348 Trial NCT05220254 Trial NCT03733210 Trial NCT03405142 Trial NCT03241940 Trial NCT03179449 Trial NCT02855086 Trial NCT02805075 Trial NCT02762266 Trial NCT02736578 Trial NCT02735356 Trial NCT02699723 Trial NCT02695628 Trial NCT02690948 Trial NCT02683824 Trial NCT02635074 Trial NCT02624518 Trial NCT02599194 Trial NCT02581787 Trial NCT02488070 Trial NCT02440308 Trial NCT02432118 Trial NCT02429804 Trial NCT02415608 Trial NCT02401347 Trial NCT02215928 Trial NCT02210858 Trial NCT02203565 Trial NCT02184533 Trial NCT02175745 Trial NCT02166983 Trial NCT02058550 Trial NCT02030405 Trial NCT02019069 Trial NCT01977677 Trial NCT01943188 Trial NCT01928030 Trial NCT01926990 Trial NCT01908166 Trial NCT01904643 Trial NCT01898403 Trial NCT01893892 Trial NCT01868503

Abstract

PROJECT SUMMARY Shared Resources are organized and maintained to meet the scientific needs of members of the Stanford Cancer Institute (SCI). Through SCI-supported Shared Resources, SCI members have access to state-of-the-art equipment, instrumentation, technical expertise, training, and educationâall designed to support highly innovative cancer research. As a matrix Cancer Center, the SCI is solely responsible for the management of two Shared Resources and supports nine others that are jointly managed with the School of Medicine (SOM) and University. CCSG funds are being requested for the support of the following eleven shared resources: Animal Tumor Models, Biomedical Informatics, Bioscience Screening, Biostatistics, Cancer Imaging, Cell Sciences Imaging, Flow Cytometry, Genomics, Human Immune Monitoring, Proteomics, and Tissue Procurement. In 2020, Dr. Artandi appointed Holden Maecker, PhD, Professor of Microbiology and Immunology, as the Associate Director for Shared Resources. Maecker is also the Director of the Service Centers and Enabling Technologies for the SOM, providing integration of SCI member needs into the overall shared resource planning and evaluation process. SCI administration oversees the management and reporting of the Shared Resources and receives feedback through annual surveys of users and from the Shared Resources internal advisory boards. The Senior Leadership Cabinet provides oversight for the overall scientific and strategic development of Shared Resources. Over the current funding period, the $6M amount of funding for the Shared Resources from the CCSG was augmented by $2.1M annually in SCI institutional support with a strong return on investment as documented by usage metrics and publications. The CCSG budget contribution to SCI Shared Resources is only $1.1M (8%) of the total operational budget ($14.4M, including CCSG and SCI funds) for all Shared Resources in CY20, with the remainder supported by institutional funds and chargebacks or grant support. The SCI requests $1.5M in annual support for eleven Shared Resources and two developing Shared Resource in the next funding period, which will be leveraged by additional $2M in SCI funds.

View original record on NIH RePORTER →